166 related articles for article (PubMed ID: 29620222)
1. miR‑29a suppresses IL‑13‑induced cell invasion by inhibiting YY1 in the AKT pathway in lung adenocarcinoma A549 cells.
Zhang Y; He S; Mei R; Kang Y; Duan J; Wei R; Xiang C; Wu Y; Lu X; Cai Z; Xiong L
Oncol Rep; 2018 Jun; 39(6):2613-2623. PubMed ID: 29620222
[TBL] [Abstract][Full Text] [Related]
2. Effect of microRNA-135a on Cell Proliferation, Migration, Invasion, Apoptosis and Tumor Angiogenesis Through the IGF-1/PI3K/Akt Signaling Pathway in Non-Small Cell Lung Cancer.
Zhou Y; Li S; Li J; Wang D; Li Q
Cell Physiol Biochem; 2017; 42(4):1431-1446. PubMed ID: 28715819
[TBL] [Abstract][Full Text] [Related]
3. MiR-186 inhibits proliferation, migration, and invasion of non-small cell lung cancer cells by downregulating Yin Yang 1.
Huang T; Wang G; Yang L; Peng B; Wen Y; Ding G; Wang Z
Cancer Biomark; 2017 Dec; 21(1):221-228. PubMed ID: 29060934
[TBL] [Abstract][Full Text] [Related]
4. Hydroxysafflor yellow A inhibited lipopolysaccharide-induced non-small cell lung cancer cell proliferation, migration, and invasion by suppressing the PI3K/AKT/mTOR and ERK/MAPK signaling pathways.
Jiang M; Zhou LY; Xu N; An Q
Thorac Cancer; 2019 Jun; 10(6):1319-1333. PubMed ID: 31055884
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of FYN suppresses the epithelial-to-mesenchymal transition through down-regulating PI3K/AKT pathway in lung adenocarcinoma.
Xue F; Jia Y; Zhao J
Surg Oncol; 2020 Jun; 33():108-117. PubMed ID: 32561075
[TBL] [Abstract][Full Text] [Related]
6. Significantly inhibitory effects of low molecular weight heparin (Fraxiparine) on the motility of lung cancer cells and its related mechanism.
Zhong GX; Gong Y; Yu CJ; Wu SF; Ma QP; Wang Y; Ren J; Zhang XC; Yang WH; Zhu W
Tumour Biol; 2015 Jun; 36(6):4689-97. PubMed ID: 25619477
[TBL] [Abstract][Full Text] [Related]
7. [CK2α Regulates the Metastases and Migration of Lung Adenocarcinoma
A549 Cell Line through PI3K/Akt/GSK-3β Signal Pathway].
Wu A; Li M; Mai Z; Li S; Yang Z
Zhongguo Fei Ai Za Zhi; 2017 Apr; 20(4):233-238. PubMed ID: 28442011
[TBL] [Abstract][Full Text] [Related]
8. GBX2, as a tumor promoter in lung adenocarcinoma, enhances cells viability, invasion and migration by regulating the AKT/ERK signaling pathway.
Wang Y; Hui J; Li R; Fu Q; Yang P; Xiao Y; Hui J
J Gene Med; 2020 Feb; 22(2):e3147. PubMed ID: 31758726
[TBL] [Abstract][Full Text] [Related]
9. miR-212-5p exerts tumor promoter function by regulating the Id3/PI3K/Akt axis in lung adenocarcinoma cells.
Chen FF; Sun N; Wang Y; Xi HY; Yang Y; Yu BZ; Li XJ
J Cell Physiol; 2020 Oct; 235(10):7273-7282. PubMed ID: 32039486
[TBL] [Abstract][Full Text] [Related]
10. Apigenin inhibits cell proliferation, migration, and invasion by targeting Akt in the A549 human lung cancer cell line.
Zhou Z; Tang M; Liu Y; Zhang Z; Lu R; Lu J
Anticancer Drugs; 2017 Apr; 28(4):446-456. PubMed ID: 28125432
[TBL] [Abstract][Full Text] [Related]
11. The HDAC2/YY1/c-Myc signaling axis regulates lung cancer cell migration and proliferation.
Ali A; Ali A; Devi HS; Daddam JR; Sarwar R; Badrealam FK
Environ Toxicol; 2023 Aug; 38(8):1989-2001. PubMed ID: 37163306
[TBL] [Abstract][Full Text] [Related]
12. MiR-4299 suppresses non-small cell lung cancer cell proliferation, migration and invasion through modulating PTEN/AKT/PI3K pathway.
Yang WB; Zhang WP; Shi JL; Wang JW
Eur Rev Med Pharmacol Sci; 2018 Jun; 22(11):3408-3414. PubMed ID: 29917192
[TBL] [Abstract][Full Text] [Related]
13. IL-13 induces YY1 through the AKT pathway in lung fibroblasts.
Guo J; Yao H; Lin X; Xu H; Dean D; Zhu Z; Liu G; Sime P
PLoS One; 2015; 10(3):e0119039. PubMed ID: 25775215
[TBL] [Abstract][Full Text] [Related]
14. Ophiopogonin B suppresses the metastasis and angiogenesis of A549 cells in vitro and in vivo by inhibiting the EphA2/Akt signaling pathway.
Chen M; Hu C; Guo Y; Jiang R; Jiang H; Zhou Y; Fu H; Wu M; Zhang X
Oncol Rep; 2018 Sep; 40(3):1339-1347. PubMed ID: 29956803
[TBL] [Abstract][Full Text] [Related]
15. Effects of TGF-β signaling blockade on human A549 lung adenocarcinoma cell lines.
Xu CC; Wu LM; Sun W; Zhang N; Chen WS; Fu XN
Mol Med Rep; 2011; 4(5):1007-15. PubMed ID: 21725601
[TBL] [Abstract][Full Text] [Related]
16.
Lu XX; Cao LY; Chen X; Xiao J; Zou Y; Chen Q
Biomed Res Int; 2016; 2016():2476842. PubMed ID: 27822469
[No Abstract] [Full Text] [Related]
17. Effects and mechanism of microRNA‑218 against lung cancer.
Chen Y; Yang JL; Xue ZZ; Cai QC; Hou C; Li HJ; Zhao LX; Zhang Y; Gao CW; Cong L; Wang TZ; Chen DM; Li GS; Luo SQ; Yao Q; Yang CJ; Zhu QS; Cao CH
Mol Med Rep; 2021 Jan; 23(1):. PubMed ID: 33179084
[TBL] [Abstract][Full Text] [Related]
18. LPCAT1 promotes brain metastasis of lung adenocarcinoma by up-regulating PI3K/AKT/MYC pathway.
Wei C; Dong X; Lu H; Tong F; Chen L; Zhang R; Dong J; Hu Y; Wu G; Dong X
J Exp Clin Cancer Res; 2019 Feb; 38(1):95. PubMed ID: 30791942
[TBL] [Abstract][Full Text] [Related]
19. WSTF promotes proliferation and invasion of lung cancer cells by inducing EMT via PI3K/Akt and IL-6/STAT3 signaling pathways.
Meng J; Zhang XT; Liu XL; Fan L; Li C; Sun Y; Liang XH; Wang JB; Mei QB; Zhang F; Zhang T
Cell Signal; 2016 Nov; 28(11):1673-82. PubMed ID: 27449264
[TBL] [Abstract][Full Text] [Related]
20. Salidroside represses proliferation, migration and invasion of human lung cancer cells through AKT and MEK/ERK signal pathway.
Ren M; Xu W; Xu T
Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):1014-1021. PubMed ID: 30880481
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]